Twitter Beğeni Hilesi

Thank you ACS Journal Cancer for highlighting work with Daniel Kwon MD @HemoncUcsf of outcomes in mCRPC patients with DDR mutations, a multi-institutional effort UCSF Helen Diller Family Comprehensive Cancer Ctr UCSF School of Medicine U-M Rogel Cancer Center UBC Medicine Prostate Cancer Foundation PCF Science

A mobile application for pts to record consults was feasible, acceptable, and a potentially valued intervention to improve decision making in the #telehealth setting for men w/ #prostatecancer. fal.cn/3l9BG #pcsm #JCOOP Daniel Kwon MD

Thanks for highlighting our work. UCSF Helen Diller Family Comprehensive Cancer Ctr

Two years into the #COVID19 pandemic & we are still worrying about all the missed #hemeonc fellow professional & career development opportunities! Excited to see our work in JCO Oncology Practice ascopubs.org/doi/full/10.12… highlighting PD #burnout & perspectives on #fellowship needs

Hiring AHP (NP/PA) for UCSF Helen Diller Family Comprehensive Cancer Ctr hospital-based oncology #HBO service! Internal and external AHPs welcome: bit.ly/UCSFNPint bit.ly/UCSFNPext bit.ly/UCSFPAint bit.ly/UCSFPAext Work w sweet (Daniel Kwon MD) and sassy (🙋🏻‍♂️) attendings 😝 UCSF Health

mercurynews.com/2022/02/03/893… thanks to the Mercury News for publishing my reflection on what doctoring has taught me about processing the irreplaceable losses of the pandemic.

Hey #oncologists and Hem-Onc Fellows Network! We’re recruiting a new UCSF Health hospital-based oncologist (#HBO)! Come join our growing inpatient solid onc group w Daniel Kwon MD and me UCSF Helen Diller Family Comprehensive Cancer Ctr 🥰 Apply: bit.ly/HBOfacultyrecr… Why I ❤️ #HBO: bit.ly/HBOtheOncologi… 🩺🥼🏥🥰

COVID‐19 outcomes in patients with cancer: Findings from the University of California health system database | Daniel Kwon MD Franklin Huang in the journal Cancer Medicine onlinelibrary.wiley.com/doi/full/10.10… #openaccess

Finally! FDA approves 177Lu-PSMA-617. Somewhat odd name (Pluvicto). Can't wait to see the prescribing information.

It's rough to wait so long to get 177Lu-PSMA-617 therapy available, and then see a patient who is in such need with a scan that would suggest great benefit (SUVs in the 60s), and then find out that doses can't be delivered for an unknown amount of time. Unbelievable!

In this JAMA Oncology Patient Page, we (Ana I. Velázquez Mañana, MD, MSc, FASCO Ivan de Kouchkovsky) wrote an easy-to-understand explanation of PSMA PET Scans in prostate cancer. jamanetwork.com/article.aspx?d… Great resource for patients. GRACE

Thanks GRACE for producing this 7-part series I did with Fred on high quality decision making in advanced prostate ca. We talk about why this is important, steps, and resources. Applicable to all cancers! youtube.com/playlist?list=…

Skeletal-related events after abiraterone or enzalutamide in patients with #mCRPC: a population-based study using the SEER-Medicare Linked Dataset. #BeyondTheAbstract with Daniel Kwon MD UCSF Helen Diller Family Comprehensive Cancer Ctr on UroToday > bit.ly/3gO41cw Urologic Oncology Matthew Bucknor @HalaBorno

Skeletal-related events after abiraterone or enzalutamide in patients with #mCRPC: a population-based study using the SEER-Medicare Linked Dataset. #BeyondTheAbstract with Daniel Kwon MD UCSF Helen Diller Family Comprehensive Cancer Ctr on UroToday > bit.ly/3gO41cw Urologic Oncology Matthew Bucknor @HalaBorno

A collaborative effort between UCSFs Cancer Genetics and Prevention Program and GU Medical Oncology. UCSF Helen Diller Family Comprehensive Cancer Ctr

Skeletal-related events after abiraterone or enzalutamide in patients with #mCRPC: a population-based study using the SEER-Medicare Linked Dataset. #BeyondTheAbstract with Daniel Kwon MD UCSF Helen Diller Family Comprehensive Cancer Ctr on UroToday > bit.ly/3gO41cw Urologic Oncology Matthew Bucknor @HalaBorno

So excited for UCSF School of Medicine 1st year medical student Joy Huang who is an amazing researcher! I’m lucky to have connected with her. 🙌🍀 #ASCO23

🎉 Great work Kevin Reyes, Daniel Kwon MD and team describing the decision-related needs of people newly diagnosed with #cancer while hospitalized. Multiple perspectives included: patients, caregivers, oncologists. Check it out: pubmed.ncbi.nlm.nih.gov/38684522/ UCSF Helen Diller Family Comprehensive Cancer Ctr UCSFHospitalMedicine